Although effective leptin therapy for treating obesity and diabetes is not established, mainly due to leptin resistance in obese patients, there are several clinical trials for combined therapies to improve the treatment of obesity-related conditions and lipodystrophy (3–6). Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.